Intelligent Bio Solutions Stock Performance

INBS Stock  USD 4.76  0.07  1.45%   
On a scale of 0 to 100, Intelligent Bio holds a performance score of 3. The company retains a Market Volatility (i.e., Beta) of -1.27, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Intelligent Bio are expected to decrease by larger amounts. On the other hand, during market turmoil, Intelligent Bio is expected to outperform it. Please check Intelligent Bio's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Intelligent Bio's current trending patterns will revert.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Intelligent Bio Solutions are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental drivers, Intelligent Bio unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(1.45)
Five Day Return
(0.83)
Year To Date Return
(39.67)
Ten Year Return
(99.98)
All Time Return
(99.98)
Last Split Factor
1:10
Last Split Date
2025-12-16
1
Intelligent Bio Solutions to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference on December 2-3, 2025
11/20/2025
2
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-...
12/18/2025
3
Intelligent Bio Solutions Announces 10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
12/31/2025
4
Intelligent Bio Solutions Announces Closing of 10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
01/02/2026
5
Why Did Intelligent Bio Solutions Stock Surge 76 percent Today - TipRanks
01/05/2026
6
Stocks To Watch Intelligent Bio Solutions Sees Relative Strength Rating Rise To 85 - Investors Business Daily
01/14/2026
7
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510 Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
01/28/2026
8
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48 percent Year-Over-Year, Surpassing 2 Million in Total ...
02/05/2026
9
Intelligent Bio Solutions GAAP EPS of -2.82, revenue of 0.89M
02/12/2026
Begin Period Cash Flow6.3 M
Total Cashflows From Investing Activities-231.8 K

Intelligent Bio Relative Risk vs. Return Landscape

If you would invest  664.00  in Intelligent Bio Solutions on November 22, 2025 and sell it today you would lose (188.00) from holding Intelligent Bio Solutions or give up 28.31% of portfolio value over 90 days. Intelligent Bio Solutions is currently generating 0.7727% in daily expected returns and assumes 20.2392% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Intelligent, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Intelligent Bio is expected to generate 26.95 times more return on investment than the market. However, the company is 26.95 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Intelligent Bio Target Price Odds to finish over Current Price

The tendency of Intelligent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.76 90 days 4.76 
about 84.06
Based on a normal probability distribution, the odds of Intelligent Bio to move above the current price in 90 days from now is about 84.06 (This Intelligent Bio Solutions probability density function shows the probability of Intelligent Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Intelligent Bio Solutions has a beta of -1.27. This usually indicates as returns on its benchmark rise, returns on holding Intelligent Bio Solutions are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Intelligent Bio is expected to outperform its benchmark. Additionally Intelligent Bio Solutions has an alpha of 0.639, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Intelligent Bio Price Density   
       Price  

Predictive Modules for Intelligent Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intelligent Bio Solutions. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.346.8226.89
Details
Intrinsic
Valuation
LowRealHigh
0.336.5226.59
Details
Naive
Forecast
LowNextHigh
0.178.6428.71
Details
1 Analysts
Consensus
LowTargetHigh
10.9212.0013.32
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Intelligent Bio. Your research has to be compared to or analyzed against Intelligent Bio's peers to derive any actionable benefits. When done correctly, Intelligent Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Intelligent Bio Solutions.

Intelligent Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Intelligent Bio is not an exception. The market had few large corrections towards the Intelligent Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intelligent Bio Solutions, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intelligent Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.64
β
Beta against Dow Jones-1.27
σ
Overall volatility
3.23
Ir
Information ratio 0.03

Intelligent Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intelligent Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intelligent Bio Solutions can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Intelligent Bio is way too risky over 90 days horizon
Intelligent Bio appears to be risky and price may revert if volatility continues
Intelligent Bio has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.05 M. Net Loss for the year was (10.6 M) with profit before overhead, payroll, taxes, and interest of 1.65 M.
Intelligent Bio Solutions currently holds about 8.28 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Latest headline from news.google.com: Acurx Pharmaceuticals Approaches Critical Phase 3 Trial Launch - AD HOC NEWS

Intelligent Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intelligent Stock often depends not only on the future outlook of the current and potential Intelligent Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intelligent Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding527.4 K
Cash And Short Term InvestmentsM

Intelligent Bio Fundamentals Growth

Intelligent Stock prices reflect investors' perceptions of the future prospects and financial health of Intelligent Bio, and Intelligent Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Intelligent Stock performance.

About Intelligent Bio Performance

Assessing Intelligent Bio's fundamental ratios provides investors with valuable insights into Intelligent Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Intelligent Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 147.66  249.78 
Return On Tangible Assets(2.13)(2.24)
Return On Capital Employed(4.22)(4.01)
Return On Assets(1.15)(1.21)
Return On Equity(4.06)(3.85)

Things to note about Intelligent Bio Solutions performance evaluation

Checking the ongoing alerts about Intelligent Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Intelligent Bio Solutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Intelligent Bio is way too risky over 90 days horizon
Intelligent Bio appears to be risky and price may revert if volatility continues
Intelligent Bio has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.05 M. Net Loss for the year was (10.6 M) with profit before overhead, payroll, taxes, and interest of 1.65 M.
Intelligent Bio Solutions currently holds about 8.28 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Latest headline from news.google.com: Acurx Pharmaceuticals Approaches Critical Phase 3 Trial Launch - AD HOC NEWS
Evaluating Intelligent Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Intelligent Bio's stock performance include:
  • Analyzing Intelligent Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Intelligent Bio's stock is overvalued or undervalued compared to its peers.
  • Examining Intelligent Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Intelligent Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Intelligent Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Intelligent Bio's stock. These opinions can provide insight into Intelligent Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Intelligent Bio's stock performance is not an exact science, and many factors can impact Intelligent Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.